AU2020387423A1 - Circulating RNA signatures specific to preeclampsia - Google Patents
Circulating RNA signatures specific to preeclampsia Download PDFInfo
- Publication number
- AU2020387423A1 AU2020387423A1 AU2020387423A AU2020387423A AU2020387423A1 AU 2020387423 A1 AU2020387423 A1 AU 2020387423A1 AU 2020387423 A AU2020387423 A AU 2020387423A AU 2020387423 A AU2020387423 A AU 2020387423A AU 2020387423 A1 AU2020387423 A1 AU 2020387423A1
- Authority
- AU
- Australia
- Prior art keywords
- twenty
- thirty
- forty
- rna
- preeclampsia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962939324P | 2019-11-22 | 2019-11-22 | |
| US62/939,324 | 2019-11-22 | ||
| PCT/US2020/061466 WO2021102236A1 (en) | 2019-11-22 | 2020-11-20 | Circulating rna signatures specific to preeclampsia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2020387423A1 true AU2020387423A1 (en) | 2021-09-30 |
Family
ID=73835822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2020387423A Abandoned AU2020387423A1 (en) | 2019-11-22 | 2020-11-20 | Circulating RNA signatures specific to preeclampsia |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US11753685B2 (https=) |
| EP (1) | EP4010495A1 (https=) |
| JP (1) | JP7797199B2 (https=) |
| CN (1) | CN113677807A (https=) |
| AU (1) | AU2020387423A1 (https=) |
| CA (1) | CA3131748A1 (https=) |
| WO (1) | WO2021102236A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019227015A1 (en) | 2018-05-25 | 2019-11-28 | Illumina, Inc. | Circulating rna signatures specific to preeclampsia |
| US11753685B2 (en) | 2019-11-22 | 2023-09-12 | Illumina, Inc. | Circulating RNA signatures specific to preeclampsia |
| US20230394492A1 (en) * | 2022-06-02 | 2023-12-07 | Noodle Analytics, Inc. | Ai-based defect diagnosis system and method |
| EP4532769A2 (en) | 2022-06-03 | 2025-04-09 | Illumina, Inc. | Circulating rna biomarkers for preeclampsia |
| WO2024124587A1 (zh) * | 2022-12-16 | 2024-06-20 | 深圳华大基因股份有限公司 | 子痫前期生物标志物及其用途 |
| CN119068988B (zh) * | 2024-08-13 | 2025-04-15 | 北京国浩宇医疗科技有限公司 | 一种针对单细胞表达谱的智能化异常检测系统 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| WO1991006678A1 (en) | 1989-10-26 | 1991-05-16 | Sri International | Dna sequencing |
| ATE377093T1 (de) | 2000-07-07 | 2007-11-15 | Visigen Biotechnologies Inc | Sequenzbestimmung in echtzeit |
| AU2002227156A1 (en) | 2000-12-01 | 2002-06-11 | Visigen Biotechnologies, Inc. | Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity |
| US7057026B2 (en) | 2001-12-04 | 2006-06-06 | Solexa Limited | Labelled nucleotides |
| WO2004018497A2 (en) | 2002-08-23 | 2004-03-04 | Solexa Limited | Modified nucleotides for polynucleotide sequencing |
| WO2004065629A1 (en) * | 2003-01-17 | 2004-08-05 | The Chinese University Of Hong Kong | Circulating mrna as diagnostic markers for pregnancy-related disorders |
| DE102004035479A1 (de) | 2004-07-14 | 2006-02-16 | Volkswagen Ag | Sicherheitssystem für einen Fahrzeugsitz |
| CA2579150C (en) | 2004-09-17 | 2014-11-25 | Pacific Biosciences Of California, Inc. | Apparatus and method for analysis of molecules |
| CA3007182A1 (en) | 2005-03-18 | 2006-09-21 | The Chinese University Of Hong Kong | Markers for prenatal diagnosis, monitoring or predicting preeclampsia |
| US7405281B2 (en) | 2005-09-29 | 2008-07-29 | Pacific Biosciences Of California, Inc. | Fluorescent nucleotide analogs and uses therefor |
| CA2648149A1 (en) | 2006-03-31 | 2007-11-01 | Solexa, Inc. | Systems and devices for sequence by synthesis analysis |
| US8343746B2 (en) | 2006-10-23 | 2013-01-01 | Pacific Biosciences Of California, Inc. | Polymerase enzymes and reagents for enhanced nucleic acid sequencing |
| EP2132343B1 (en) | 2007-03-01 | 2012-08-29 | Université Catholique de Louvain | Method for the determination and the classification of rheumatic conditions |
| DE102007031708A1 (de) | 2007-07-06 | 2009-01-08 | Dade Behring Marburg Gmbh | Bestimmung der von Willebrand Faktor-Aktivität in Abwesenheit von Ristocetin |
| EP2234483A4 (en) * | 2008-01-27 | 2011-04-27 | Rosetta Genomics Ltd | METHOD AND COMPOSITIONS FOR DIAGNOSIS OF PREGNANCY COMPLICATIONS |
| WO2010033553A2 (en) | 2008-09-16 | 2010-03-25 | University Of Florida Research Foundation Inc. | Gene expression related to preeclampsia |
| EP2370599B1 (en) | 2010-01-19 | 2015-01-21 | Verinata Health, Inc | Method for determining copy number variations |
| US20120270739A1 (en) | 2010-01-19 | 2012-10-25 | Verinata Health, Inc. | Method for sample analysis of aneuploidies in maternal samples |
| AU2012276702B2 (en) | 2011-06-29 | 2017-02-09 | Toray Industries, Inc. | Membrane filtration method and membrane filtration device |
| US20160289762A1 (en) | 2012-01-27 | 2016-10-06 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for profiliing and quantitating cell-free rna |
| WO2014132244A1 (en) | 2013-02-28 | 2014-09-04 | The Chinese University Of Hong Kong | Maternal plasma transcriptome analysis by massively parallel rna sequencing |
| BR112017007962A2 (pt) | 2014-10-24 | 2018-01-23 | Koninklijke Philips Nv | método implementado por computador, aparelho, mídia de armazenamento, programa de computador, kit, e, uso do kit |
| US20170234874A1 (en) | 2015-10-07 | 2017-08-17 | Clearbridge Biophotonics Pte Ltd. | Integrated visual morphology and cell protein expression using resonance-light scattering |
| US11753685B2 (en) | 2019-11-22 | 2023-09-12 | Illumina, Inc. | Circulating RNA signatures specific to preeclampsia |
| CN111750067A (zh) | 2020-07-07 | 2020-10-09 | 精进电动科技股份有限公司 | 一种用于双动力源驱动减速器的差速锁及驻车结构 |
| EP4532769A2 (en) | 2022-06-03 | 2025-04-09 | Illumina, Inc. | Circulating rna biomarkers for preeclampsia |
-
2020
- 2020-11-20 US US16/953,480 patent/US11753685B2/en active Active
- 2020-11-20 WO PCT/US2020/061466 patent/WO2021102236A1/en not_active Ceased
- 2020-11-20 JP JP2021558675A patent/JP7797199B2/ja active Active
- 2020-11-20 EP EP20824848.4A patent/EP4010495A1/en active Pending
- 2020-11-20 AU AU2020387423A patent/AU2020387423A1/en not_active Abandoned
- 2020-11-20 CA CA3131748A patent/CA3131748A1/en active Pending
- 2020-11-20 CN CN202080026261.4A patent/CN113677807A/zh active Pending
-
2022
- 2022-12-29 US US18/091,186 patent/US12359256B2/en active Active
-
2025
- 2025-04-16 US US19/180,344 patent/US20250270646A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US11753685B2 (en) | 2023-09-12 |
| US20250270646A1 (en) | 2025-08-28 |
| US20230135486A1 (en) | 2023-05-04 |
| JP7797199B2 (ja) | 2026-01-13 |
| JP2023501760A (ja) | 2023-01-19 |
| US20210155987A1 (en) | 2021-05-27 |
| WO2021102236A1 (en) | 2021-05-27 |
| US12359256B2 (en) | 2025-07-15 |
| EP4010495A1 (en) | 2022-06-15 |
| CN113677807A (zh) | 2021-11-19 |
| CA3131748A1 (en) | 2021-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7678837B2 (ja) | 妊娠高血圧腎症に特異的な循環ｒｎａシグネチャー | |
| US12359256B2 (en) | Circulating RNA signatures specific to preeclampsia | |
| WO2015117204A9 (en) | Biomarker signature method, and apparatus and kits therefor | |
| WO2022192467A1 (en) | Prediction of preeclampsia risk using circulating, cell-free rna | |
| US20230392207A1 (en) | Circulating rna biomarkers for preeclampsia | |
| HK40062225A (en) | Circulating rna signatures specific to preeclampsia | |
| HK40015099A (en) | Circulating rna signatures specific to preeclampsia | |
| US20250361562A1 (en) | Cell-free dna signals as biomarkers of preeclampsia | |
| HK40015099B (zh) | 对先兆子痫具有特异性的循环rna标识 | |
| HK40050272B (en) | Circulating rna signatures specific to preeclampsia | |
| HK40050272A (en) | Circulating rna signatures specific to preeclampsia | |
| Montaner Domènech | Development of tools for the analysis of cell-free DNA in human blood: Application in the noninvasive prenatal testing field |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |